Review of Anaesthesia and Analgesia in Patients with COVID-19 in Brazil

Review of Anaesthesia and Analgesia in Patients with COVID-19 in Brazil

Author Info

Corresponding Author
Makson Gleydson Brito de Oliveira
Department of Medicine, Federal University of Sergipe, Lagarto, Sergipe, Brazil


Severe acute respiratory syndrome (COVID-19), produced by SARS-CoV-2, remains a challenge for modern medicine and a global health problem. For every 100 patients with COVID-19, about 20 need hospital care. In addition, some patients will be intubated and others under mechanical ventilation. Therefore, it is necessary to use drugs as a sedative and analgesic purpose, mainly. Thus, this study brings a survey on the drugs that can be used for the management of patients with COVID-19 in cases of intubation and mechanical ventilation in Brazil. In this paper, we will report the classes of anaesthetic and analgesic drugs. Highlighting the clinical indications for use, pharmacological characteristics of each drug in terms of doses, pharmacokinetics, pharmacodynamics and possible side effects and, in addition, peculiarities of drugs related to use in patients with COVID-19, when possible.

Article Info

Article Type
Review Article
Publication history
Received: Tue 11, Aug 2020
Accepted: Tue 25, Aug 2020
Published: Tue 08, Sep 2020
© 2023 Makson Gleydson Brito de Oliveira. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.ACR.2020.01.08